Study of EGFR-TKI to Asymptomatic Brain Metastases of NSCLC
NCT02250846
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
70
Enrollment
OTHER
Sponsor class
Conditions
Asymptomatic Brain Metastases of Non Small Cell Lung Cancer
Interventions
DRUG:
EGFR-TKI
Sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology